Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription

EMBO Journal

Volumn 20, Issue 20, 2001, Pages 5737-5747

  de Borja, Patrick Fojas ^a,b   Collins, N Keith ^c,d   Du, Ping ^a,b   Azizkhan Clifford, Jane ^e   Mudryj, Maria ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Durham Veterans Affairs   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cyclin A; Cyclin dependent kinase; Sp1; Transcription

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CARCINOGENESIS; CELL CYCLE; COMPLEX FORMATION; CONTROLLED STUDY; DNA BINDING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ANIMALS; CYCLIN A; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMANS; MACROMOLECULAR SUBSTANCES; MICE; PHOSPHORYLATION; PHOSPHOSERINE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SP1 TRANSCRIPTION FACTOR; TETRAHYDROFOLATE DEHYDROGENASE; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

ANIMALIA;

EID: 0035887030     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.20.5737     Document Type: Article

References (66)

1. Deregulation of specific E2F complexes by the v-mos oncogene
2. Casein kinase II-mediated phosphorylation of the C-terminus of Sp1 decreases its DNA binding activity
3. Transcription from TATA-less promoters: Dihydrofolate reductase as a model
4. Increased level of p21 in human ovarian tumors is associated with increased expression of cdk2, cyclin A and PCNA
5. Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3
6. Growth/cell cycle regulation of Sp1 phosphorylation
7. Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter
8. Over-expression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis
9. Phosphorylation of very lysine-rich histone in Physarum polycephalum. Correlation with chromosome condensation
10. Over-expression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma
11. p53 and cyclin A protein expression in squamous carcinoma of the esophagus
12. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein
13. Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation
14. Sp3 represses transcription when tethered to promoter DNA or targeted to promoter proximal RNA
15. Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM
16. 1 arrest
17. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts
18. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription
19. Modulation of Sp1 activity by a cyclin A/CDK complex
20. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein
21. Expression of cell cycle markers in colorectal carcinoma: Superiority of cyclin A as an indicator of poor prognosis
22. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors
23. 1 cyclin-dependent kinases
24. The role of RB in cell cycle control
25. Primary keratinocytes have an adhesion dependent S-phase checkpoint that is absent in immortalized cell lines
26. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
27. GC box-binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase
28. Role of E2F in cell cycle control and cancer
29. Cloning of GT box-binding proteins: A novel Sp1 multigene family regulating T-cell receptor gene expression
30. Whole genome PCR: Application to the identification of sequences bound by gene regulatory proteins
31. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2
32. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase
33. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S-phase checkpoint
34. Inhibition of p53-mediated growth arrest by over-expression of cyclin-dependent kinases
35. The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter
36. Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in cajal bodies promotes histone gene transcription
37. Cyclin A message stability varies with the cell cycle
38. Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains
39. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A
40. Cyclin ubiquitylation: The destructive end of mitosis
41. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
42. Cyclin A is required at two points in the human cell cycle
43. A- and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes
44. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
45. E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53
46. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
47. 1 by p27Kip1
48. Potentiation of human estrogen receptor α-transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex
49. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase
50. Activation of human B-MYB by cyclins
51. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties
52. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site
53. Cancer cell cycles
54. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner
55. Deregulated expression of E2F-1 induces cyclin A- and E-associated kinase activities independently from cell cycle position
56. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter
57. Sp4, a member of the Sp1-family of zinc finger transcription factors, is required for normal murine growth, viability and male fertility
58. Functional analysis of GC element binding and transcription in the hamster dihydrofolate reductase gene promoter
59. 1 cyclin-Cdk protein kinase activity, is related to p21
60. The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A
61. Transcription of histone H4, H3 and H1 cell cycle genes: Promoter factor HiNF-D contains CDC2, cyclin A and an RB-related protein
62. A GT-rich sequence binding the transcription factor Sp1 is crucial for high expression of the human type VII collagen gene (COL7A1) in fibroblasts and keratinocytes
63. TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins
64. p21 is a universal inhibitor of cyclin kinases
65. Down-regulation of the cyclin A promoter by transforming growth factor-β1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein